AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glitra MP 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sanatra Health Care

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glitra MP 1mg/500mg Tablet

DiaBeta Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. DiaBeta Duo is only one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; suitability may be affected. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Glitra MP 1mg/500mg Tablet

No information provided. Please provide the text you wish to be rephrased.

Uses of Glitra MP 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glitra MP 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glitra MP 1mg/500mg Tablet should be administered with a meal.

Common Side effects of Glitra MP 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitra MP 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glitra MP 1mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Glitra MP 1mg/500mg Tablet works:

Glitra MP tablets (1mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glitra MP 1mg/500mg Tablet with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitra MP 1mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glitra MP 1mg/500mg Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glitra MP 1mg/500mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glitra MP 1mg/500mg Tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glitra MP 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glitra MP 1mg/500mg Tablet :

Should you forget to take your Glitra MP 1mg/500mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Glitra MP 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glitra MP 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glitra MP 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glitra MP 1mg/500mg Tablets and seek immediate medical attention.
Glitra MP 1mg/500mg Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glitra MP 1mg/500mg Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glitra MP 1mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glitra MP 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glitra MP 1mg/500mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glitra MP 1mg/500mg Table...
80
MRP 93
13% off